foxo4-dri peptide senolytic 2024 study

foxo4-dri peptide senolytic 2024 study PDF) Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri peptide senolytic 2024 study PDF) Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Peptide inhibitors targeting FOXO4-p53 interactions
Brand: lagence-mr.com
SKU: 24168644014
Price: 26.46 USD
Availability: InStock
Rating: 4.4257 (5 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Buy FOXO4 DRI 10mg Peptide EU Tested Particle Peptides Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry

SKU: 24168644014 · From lagence-mr.com

4.4

USD26.46 USD76.46

Pay in 4 interest-free payments of $6.62 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 17 - Sep 22

Description

Recent progress has been made in the area of kinase specificity through largescale discovery of activesite preferences using peptide arrays (Johnson et al , 2023)